Vanda sues U.S. government for misappropriation of trade secrets

Vanda Pharmaceuticals announced its action against the federal government for the "uncompensated taking and misuse of Vanda’s trade secrets and confidential information." The company stated: "Vanda alleges that the U.S. Food and Drug Administration improperly provided confidential details from Vanda’s drug master files for its products, Hetlioz and Fanapt, to generic drug manufacturers during the FDA’s review of the manufacturers’ Abbreviated New Drug Applications. The action was filed in the United States Court of Federal Claims and seeks an award of economic damages."